Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

October 11, 2024 | Friday | News
Hyphens Pharma launches treatment for Atopic dermatitis (Eczema) expanding it’s Ceradan® series

Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, ...

September 19, 2024 | Thursday | News
Addressing Supply Chain Vulnerabilities in the Global Pharmaceutical Industry

Industries with international operations face increasing vulnerability to supply chain disruptions. This risk is particu...

August 22, 2024 | Thursday | News
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market

Apexelsin, a generic drug from China been approved by the European Commission. Apexelsin is a generic dru...

July 31, 2024 | Wednesday | News
China Life Science Conference and China Life Science Expo (CILSE) Set to Drive Innovation and Collaboration in Guangzhou

The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...

March 7, 2024 | Thursday | News
Asia Pacific Forum on Precision Cancer Treatment at Taiwan Healthcare+ Expo 2023, Wraps Up with Robust Discussions and Deep Insights

The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...

December 1, 2023 | Friday | News
“Generic manufacturers will likely face increasing challenges such as pricing pressures driven by 'un-branding' efforts”

How did the company perform during FY 2022-23?  The company is currently in a recovery phase following the impact ...

July 4, 2023 | Tuesday | Opinion
Generic manufacturers from India & Indonesia bring affordable drug for cancer treatment

The Medicines Patent Pool (MPP), a United Nations-backed public health organisation, has signed sublicence agreemen...

June 23, 2023 | Friday | News
Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M

Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...

February 28, 2023 | Tuesday | News
Indian pharma firm Venus Remedies gets marketing approval for cancer drugs in Uzbekistan, Palestine

Indian pharmaceutical company Venus Remedies has received marketing authorisation for its generic cancer drugs from Uzbe...

February 23, 2023 | Thursday | News
ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist

Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...

September 28, 2022 | Wednesday | News
Portfolio Management and Pipeline Optimization for Generics (15th Edition) conference to unravel global generic pharma market opportunities

Pharmaceutical companies need to ensure they have a competitive edge in the market while adapting to evolving industry b...

August 8, 2022 | Monday | News
35 manufacturers sign agreements to produce generic versions of Pfizer's oral COVID-19 drug

The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer's o...

March 18, 2022 | Friday | News
Taiwan approves new first-line treatment for advanced renal cell carcinoma

Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...

January 31, 2022 | Monday | News
Eisai to market Gilead’s rheumatoid arthritis drug in Asia

Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...

December 23, 2021 | Thursday | News
Biocon partners with Tabuk Pharma to commercialise speciality generic medicines in Middle East

Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...

December 8, 2021 | Wednesday | News
C2 PHARMA Completes Multiple Local Regulatory Filings and Expands Portfolio

Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...

November 10, 2021 | Wednesday | News
Patient access to gene therapies for cancer set to increase in next decade: GlobalData

Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...

June 25, 2021 | Friday | News